Return on investment tool: colorectal cancer
A tool to help local commissioners understand the economic case for early diagnosis of bowel cancer, colon cancer and rectal cancer.
Documents
Details
The return on investment (ROI) tool brings together clinical commissioning group (CCG) data with research about the costs and long-term benefits of early diagnosis of colorectal cancer.
Local commissioners can:
-
see how their CCG is performing
-
calculate the difference that specific interventions could make to cost-effectiveness and patient outcomes in their local area
The report and user guide:
-
describe the most cost-effective local interventions, focusing on early diagnosis as well as other phases of the colorectal care pathway
-
show you how to use the ROI tool
If you have any questions or feedback about the tool, email [email protected].